Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Retained Earnings (2018 - 2025)

AVITA Medical filings provide 8 years of Retained Earnings readings, the most recent being -$408.4 million for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 20962.45% to -$408.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$408.4 million, a 20962.45% decrease, with the full-year FY2025 number at -$408.4 million, down 20962.45% from a year prior.
  • Retained Earnings hit -$408.4 million in Q4 2025 for AVITA Medical, down from -$1.4 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $8.0 million in Q3 2023 to a low of -$408.4 million in Q4 2025.
  • Median Retained Earnings over the past 5 years was -$109.4 million (2021), compared with a mean of -$145.7 million.
  • Biggest five-year swings in Retained Earnings: surged 103.59% in 2022 and later tumbled 24552.51% in 2025.
  • AVITA Medical's Retained Earnings stood at -$235.9 million in 2021, then skyrocketed by 103.23% to $7.6 million in 2022, then tumbled by 4006.77% to -$298.0 million in 2023, then soared by 99.35% to -$1.9 million in 2024, then crashed by 20962.45% to -$408.4 million in 2025.
  • The last three reported values for Retained Earnings were -$408.4 million (Q4 2025), -$1.4 million (Q3 2025), and -$383.6 million (Q2 2025) per Business Quant data.